INTRODUCTION: Chronic prostatitis is a widespread urological disease with a lengthy course and a propensity to frequent recurrences.
Adequate response to anti-inflammatory therapy is lacking in a high percentage of patients, which causes them to seek medical advice from different doctors. Thus, the physicians are challenged to look for other reasons causing the pathological symptoms.
MATERIAL AND METHODS: We have reviewed the patients with treatment-resistant chronic bacterial prostatitis (CBP) from the perspective of psychosomatic medicine. For the evaluation of primary mental status and treatment control we used standard approved questionnaires. All 337 CBP patients initially underwent therapy aimed at pathogen eradication. If psychopathological symptoms were evident and dominated over urological ones, the patients were referred to psychiatric evaluation and treatment.
RESULTS: The frequency of concomitant psychosomatic disorders (PSD) in patients with CBP was 28.2% and neurotic disorders - 26.4%. Adequate multimodal anti-inflammatory therapy followed by a few sessions of psychotherapy decreased the manifestations of PSD in 30.5%, neurotic disorders in 51.7%, and premature ejaculation in 60.5% of patients with CBP. The addition of pharmacotherapy to psychotherapy is effective in treatment-resistant cases. However, after multimodal treatment, 31.5% of pts. with PSD and 13.5% of pts. with neurotic disorders still remain treatment-resistant and required in-depth long-term psychiatric care.
CONCLUSIONS: A significant portion of CBP patients were diagnosed with neurotic, psychosomatic, and/or depressive disorders. Antibacterial and anti-inflammatory therapy, when followed by appropriate psychotherapy and pharmacotherapy, significantly decrease the manifestations of mental disorders in CBP patients.
Written by:
Banyra O, Ivanenko O, Nikitin O, Shulyak A. Are you the author?
Lviv Municipal Polyclinic, Lviv, Ukraine; The Communal Institution of Lviv City Council «Lviv Regional Clinical Psycho-Neurological Centre», In-patient Department No.2, Lviv, Ukraine; O.O. Bogomolets National Medical University, Kiev, Ukraine; Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
Reference: Cent European J Urol. 2013;66(1):93-100.
doi: 10.5173/ceju.2013.01.art29
PubMed Abstract
PMID: 24579003
UroToday.com Prostatitis Section
